October 15th 2020
Shuo Ma, MD, PhD, discusses the need to develop novel agents to treat patients with chronic lymphocytic leukemia who develop resistance to BTK inhibitors.
September 24th 2020
Shuo Ma, MD, PhD, discusses the utility of BTK inhibitors in relapsed/refractory chronic lymphocytic leukemia.
September 9th 2020
Shuo Ma, MD, PhD, highlights ongoing research with BTK inhibitors in B-cell malignancies.